Regenique Group Limited (RGGG)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	166.50M
Revenue (ttm)	10.76M
Net Income (ttm)	2.80M
Shares Out	37.00M
EPS (ttm)	0.08
PE Ratio	59.47
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About RGGG

Regenique Group is a customer-centric, science-backed aesthetics services provider. We prioritize delivering an unparalleled, premium experience for our customers by emphasizing safety, privacy and patient comfort. In addition to the market’s prevailing medi-aesthetics treatments, our suite of science-backed aesthetics services also includes bio-regenerative treatments and other advanced therapies. Our services are rendered through five strategically located clinics staffed by experienced doctors and equipped with advanced medical devices. Our ...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2009
• Employees: 58
• Stock Exchange: NASDAQ
• Ticker Symbol: RGGG
• Website: https://regeniquegroup.com/

Financial Performance

Financial numbers in SGD